Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
This study sheds light on the cognitive challenges associated with PCOS, revealing that women with the condition may face significant cognitive performance gaps. Understanding these associations is crucial for developing targeted interventions and support mechanisms for patients.
Neurology February 6th 2024
Hematology Advisor
Advancements in von Willebrand Disease (VWD) treatments, including emicizumab and BT200 (rondoraptivon pegol), are heralding a new age of personalized care, addressing the complex needs of patients with this challenging bleeding disorder.
Hematology February 5th 2024
Psychiatry Advisor
A recent JAMA Network Open study reveals Trauma Center Trauma-Sensitive Yoga as a highly acceptable and effective treatment for PTSD in women veterans, exhibiting a higher completion rate than Cognitive Processing Therapy.
Psychiatry January 24th 2024
Zurzuvae represents a novel approach in postpartum depression therapy, with clinical trials revealing substantial symptom reduction within the initial treatment period. This advancement offers a new horizon in PPD management for healthcare professionals.
Obstetrics & Gynecology January 23rd 2024
Oncology News Central (ONC)
In a major stride for cervical cancer treatment, the FDA-approved pembrolizumab in combination with CRT demonstrates significant improvement in progression-free survival for FIGO 2014 stage III-IVA patients, marking a pivotal change in therapeutic approaches.
Hematology/Oncology January 22nd 2024
The study reveals a significant increase in hospital admissions due to adrenal insufficiency among young women, with psychosocial factors playing a crucial role.
Endocrinology, Diabetes, Metabolism January 3rd 2024